Literature DB >> 18634568

Interactions of Sox10 and Egr2 in myelin gene regulation.

Erin A Jones1, Sung-Wook Jang, Gennifer M Mager, Li-Wei Chang, Rajini Srinivasan, Nolan G Gokey, Rebecca M Ward, Rakesh Nagarajan, John Svaren.   

Abstract

Myelination in the PNS is accompanied by a large induction of the myelin protein zero (Mpz) gene to produce the most abundant component in peripheral myelin. Analyses of knockout mice have shown that the EGR2/Krox20 and SOX10 transcription factors are required for Mpz expression. Our recent work has shown that the dominant EGR2 mutations associated with human peripheral neuropathies cause disruption of EGR2/SOX10 synergy at specific sites, including a conserved enhancer element in the first intron of the Mpz gene. Further investigation of Egr2/Sox10 interactions reveals that activation of the Mpz intron element by Egr2 requires both Sox10-binding sites. In addition, both Egr1 and Egr3 cooperate with Sox10 to activate this element, which indicates that this capacity is conserved among Egr family members. Finally, a conserved composite structure of Egr2/Sox10-binding sites in the genes encoding Mpz, myelin-associated glycoprotein and myelin basic protein genes was used to screen for similar modules in other myelin genes, revealing a potential regulatory element in the periaxin gene. Overall, these results elucidate a working model for developmental regulation of Mpz expression, several facets of which extend to regulation of other peripheral myelin genes.

Entities:  

Year:  2007        PMID: 18634568      PMCID: PMC2605513          DOI: 10.1017/S1740925X08000173

Source DB:  PubMed          Journal:  Neuron Glia Biol        ISSN: 1740-925X


  50 in total

1.  A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease.

Authors:  E Bellone; E Di Maria; S Soriani; A Varese; L L Doria; F Ajmar; P Mandich
Journal:  Hum Mutat       Date:  1999-10       Impact factor: 4.878

2.  Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.

Authors:  N Bondurand; M Girard; V Pingault; N Lemort; O Dubourg; M Goossens
Journal:  Hum Mol Genet       Date:  2001-11-15       Impact factor: 6.150

3.  Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies.

Authors:  L E Warner; J Svaren; J Milbrandt; J R Lupski
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

4.  Different consequences of EGR2 mutants on the transactivation of human Cx32 promoter.

Authors:  Marco Musso; Piercesare Balestra; Franco Taroni; Emilia Bellone; Paola Mandich
Journal:  Neurobiol Dis       Date:  2003-02       Impact factor: 5.996

5.  Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination.

Authors:  Nam Le; Rakesh Nagarajan; James Y T Wang; Toshiyuki Araki; Robert E Schmidt; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-03       Impact factor: 11.205

6.  Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control.

Authors:  Julien Ghislain; Carole Desmarquet-Trin-Dinh; Pascale Gilardi-Hebenstreit; Patrick Charnay; Monique Frain
Journal:  Development       Date:  2003-03       Impact factor: 6.868

7.  Hypomorphic Sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages.

Authors:  Silke Schreiner; François Cossais; Kerstin Fischer; Stefanie Scholz; Michael R Bösl; Bettina Holtmann; Michael Sendtner; Michael Wegner
Journal:  Development       Date:  2007-08-15       Impact factor: 6.868

8.  Axons regulate Schwann cell expression of the major myelin and NGF receptor genes.

Authors:  G Lemke; M Chao
Journal:  Development       Date:  1988-03       Impact factor: 6.868

9.  In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.

Authors:  Sung-Wook Jang; Scott E LeBlanc; Avtar Roopra; Lawrence Wrabetz; John Svaren
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more
  39 in total

1.  Developmental regulation of microRNA expression in Schwann cells.

Authors:  Nolan G Gokey; Rajini Srinivasan; Camila Lopez-Anido; Courtney Krueger; John Svaren
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.

Authors:  Sung-Wook Jang; Rajini Srinivasan; Erin A Jones; Guannan Sun; Sunduz Keles; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

3.  Differential Sox10 genomic occupancy in myelinating glia.

Authors:  Camila Lopez-Anido; Guannan Sun; Matthias Koenning; Rajini Srinivasan; Holly A Hung; Ben Emery; Sunduz Keles; John Svaren
Journal:  Glia       Date:  2015-05-14       Impact factor: 7.452

4.  Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies.

Authors:  John Svaren; John J Moran; Xingyao Wu; Riccardo Zuccarino; Chelsea Bacon; Yunhong Bai; Raghu Ramesh; Laurie Gutmann; Daniel M Anderson; Derek Pavelec; Michael E Shy
Journal:  Ann Neurol       Date:  2019-04-22       Impact factor: 10.422

5.  Dual specificity phosphatase 15 regulates Erk activation in Schwann cells.

Authors:  José F Rodríguez-Molina; Camila Lopez-Anido; Ki H Ma; Chongyu Zhang; Tyler Olson; Katharina N Muth; Matthias Weider; John Svaren
Journal:  J Neurochem       Date:  2017-01-09       Impact factor: 5.372

6.  SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter.

Authors:  Chani J Hodonsky; Erica L Kleinbrink; Kira N Charney; Megana Prasad; Seneca L Bessling; Erin A Jones; Rajini Srinivasan; John Svaren; Andrew S McCallion; Anthony Antonellis
Journal:  Mol Cell Neurosci       Date:  2011-10-19       Impact factor: 4.314

Review 7.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

8.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

9.  SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2.

Authors:  Elizabeth A Fogarty; Megan H Brewer; Jose F Rodriguez-Molina; William D Law; Ki H Ma; Noah M Steinberg; John Svaren; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

10.  Functional and comparative genomics analyses of pmp22 in medaka fish.

Authors:  Junji Itou; Mikita Suyama; Yukio Imamura; Tomonori Deguchi; Kazuhiro Fujimori; Shunsuke Yuba; Yutaka Kawarabayasi; Takashi Kawasaki
Journal:  BMC Neurosci       Date:  2009-06-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.